pI: 8.1105 |
Length (AA): 58 |
MW (Da): 6746 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
14 | 58 | 1twf (L) | 26 | 70 | 40.00 | 0 | 0.84 | 1.09 | 0.71 |
5 | 40 | 3pwf (A) | 129 | 161 | 42.00 | 0.38 | 0.82 | 1.00689 | 0.12 |
13 | 58 | 1twf (L) | 25 | 70 | 39.00 | 0 | 0.99 | 1.1529 | 1.2 |
14 | 50 | 2lcq (A) | 126 | 161 | 33.00 | 0.005 | 0.76 | 0.968131 | 0.42 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | gametocyte, sporozoite, early ring, early trophozoite, late ring, Oocyst, Ring, Sporozoite, Female Gametocyte, Male Gametocyte. | PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, late trophozoite. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 16 hs, intra-erythrocytic - 48 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 0 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | intra-erythrocytic - 40 hs. | Otto TD |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_130124)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G41010 | DNA-directed RNA polymerase NRPB12/NRPD12/NRPE12 |
Candida albicans | CaO19.7255 | DNA-directed RNA polymerase |
Caenorhabditis elegans | CELE_F23B2.13 | Protein RPB-12 |
Cryptosporidium parvum | cgd7_3240 | transcription activator, putative |
Dictyostelium discoideum | DDB_G0283365 | RNA polymerase I core subunit |
Drosophila melanogaster | Dmel_CG34186 | CG34186 gene product from transcript CG34186-RA |
Echinococcus granulosus | EgrG_000657300 | dna directed rna polymerases i ii and iii |
Echinococcus multilocularis | EmuJ_000657300 | DNA directed RNA polymerases I, II, and III |
Homo sapiens | ENSG00000147669 | polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa |
Loa Loa (eye worm) | LOAG_10524 | hypothetical protein |
Mus musculus | ENSMUSG00000045996 | polymerase (RNA) II (DNA directed) polypeptide K |
Mus musculus | 100862456 | DNA-directed RNA polymerases I, II, and III subunit RPABC4-like |
Mus musculus | 102641086 | DNA-directed RNA polymerases I, II, and III subunit RPABC4-like |
Oryza sativa | 9269422 | Os01g0530366 |
Oryza sativa | 9272152 | Os05g0151800 |
Oryza sativa | 9266234 | Os07g0105100 |
Plasmodium berghei | PBANKA_1355800 | DNA-directed RNA polymerases I, II, and III subunit RPABC4, putative |
Plasmodium falciparum | PF3D7_1342700 | DNA-directed RNA polymerases I, II, and III subunit RPABC4, putative |
Plasmodium knowlesi | PKNH_1258700 | DNA-directed RNA polymerases I, II, and III subunit RPABC4, putative |
Plasmodium vivax | PVX_083032 | transcription activator, putative |
Saccharomyces cerevisiae | YHR143W-A | DNA-directed RNA polymerase core subunit RPB12 |
Schistosoma japonicum | Sjp_0308900 | ko:K03009 DNA-directed RNA Polymerase II subunit K, putative |
Schistosoma mansoni | Smp_132030 | hypothetical protein |
Schmidtea mediterranea | mk4.004777.01 | |
Toxoplasma gondii | TGME49_254140 | DNA-directed RNA polymerase II RPABC4 |
Trichomonas vaginalis | TVAG_040880 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_F23B2.13 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F23B2.13 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F23B2.13 | Caenorhabditis elegans | sterile | wormbase |
YHR143W-A | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1355800 | Plasmodium berghei | Essential | plasmo |
TGME49_254140 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.